✦ LIBER ✦

Evaluation and improvement of bioavailability of a new angiotensin II receptor antagonist, 2-butyl-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl-1H-benzimidazole-7-carboxylic acid by making prodrug

✍ Scribed by Yoshinobu Yoshimura; Norio Tada; Keiji Kubo; Miwa Miyamoto; Yoshiyuki Inada; Kohei Nishikawa; Takehiko Naka

Book ID: 113366743
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 598 KB
Volume: 103
Category: Article
ISSN: 0378-5173
DOI: 10.1016/0378-5173(94)90197-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: A Non-peptide Angio

ChemInform Abstract: A Non-peptide Angiotensin II Receptor Antagonist: 2-Butyl-6-methyl-5-(1-oxopyrid-2-yl)-1-{ [2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazo[5,4-b]pyridine Methanol Solvate.

✍ Yong-Seok Heo; Kyu Yang Yi; Sung Eun Yoo; Whanchul Shin 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 1 views

structure (organic substances)

Synthesis of [14C]KT3-671, 2-Propyl-8-ox

Synthesis of [14C]KT3-671, 2-Propyl-8-oxo-1-[ (2′-(1H-[14C] tetrazole-5-yl) biphenyl-4-yl) methyl]-4,5,6, 7-tetrahydro-cycloheptimidazole, a novel potent nonpeptide angiotensin II receptor antagonist

✍ Naoto Ueyama; Takashi Yanagisawa; Tsuyoshi Tomiyama 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 1 views

## Abstract 2‐Propyl‐8‐oxo‐1‐[(2′‐(1H‐tetrazole‐5‐yl) biphenyl‐4‐yl)methyl]‐4, 5, 6, 7‐tetrahydrocyclohept imidazole (KT3‐671), which has been found to be a potent and selective angiotesin II receptor antagonist, was synthesized in ^14^C‐labelled form by using potassium[^14^C]‐cyanide. [^14^C](KT3‐

Determination of 5-n-Butyl-4-{4-[2-(1H-t

Determination of 5-n-Butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichloridephenyl)-3H-1,2,4-triazol-3-one, a New Angiotensin Type 1 Receptor Antagonist in Rat Plasma by LC-ESI-MS: Application to Pharmacokinetic Studies

✍ Bei Yan; Guang-ji Wang; Jian-guo Sun; Fen-zhi Sun; Xiao-yu Li; Xiao-ming Wu; Jin 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 345 KB

Identification of the major metabolites

Identification of the major metabolites of 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichloridephenyl)-3H-1,2,4-triazol-3-one, a new angiotensin type 1 receptor antagonist, in rat bile by HPLC–diode array detection–MS and HPLC-MS/MS

✍ Bei Yan; Guangji Wang; Jianguo Sun; Xiaoyu Li; Yuanting Zheng; Hua Ai; Hua Lv; X 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

The Discovery of N -((2 H -Tetrazol-5-yl

The Discovery of N -((2 H -Tetrazol-5-yl)methyl)-4-(( R )-1-((5 r ,8 R )-8-( tert -butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist

✍ DeMong, Duane; Dai, Xing; Hwa, Joyce; Miller, Michael; Lin, Sue-Ing; Kang, Ling; 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 529 KB

Determination of (+)-5-(2,3-dihydrobenzo

Determination of (+)-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-8-nitro-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol (NNC 01-0687), a novel dopamine D-1 receptor antagonist, in plasma by solid-phase extraction and high-performance liquid chromatography

✍ Jeppe V. Christensen 📂 Article 📅 1992 🏛 Elsevier Science ⚖ 337 KB